These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 18200378)

  • 21. Fatal eosinophilia myalgia syndrome in a marrow transplant patient attributed to total parenteral nutrition with a solution containing tryptophan.
    de Oliveira JS; Auerbach SB; Sullivan KM; Sale GE
    Bone Marrow Transplant; 1993 Feb; 11(2):163-7. PubMed ID: 8435665
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tryptophan toxicity: a pharmacoepidemiologic review of eosinophilia-myalgia syndrome.
    Milburn DS; Myers CW
    DICP; 1991 Nov; 25(11):1259-62. PubMed ID: 1763543
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Eosinophilia-myalgia syndrome in patients ingesting a single source of L-tryptophan.
    Henning KJ; Jean-Baptiste E; Singh T; Hill RH; Friedman SM
    J Rheumatol; 1993 Feb; 20(2):273-8. PubMed ID: 8474064
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Eosinophilia-myalgia syndrome. Clinical aspects and follow-up of 10 patients].
    Mensing H; Schallreuter KU; Senff H; Steinkraus V
    Hautarzt; 1992 Jul; 43(7):436-40. PubMed ID: 1506202
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The cause and pathogenesis of the eosinophilia-myalgia syndrome.
    Varga J; Uitto J; Jimenez SA
    Ann Intern Med; 1992 Jan; 116(2):140-7. PubMed ID: 1727618
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epidemiology of potential association between L-tryptophan ingestion and eosinophilia-myalgia syndrome.
    Daniels SR; Hudson JI; Horwitz RI
    J Clin Epidemiol; 1995 Dec; 48(12):1413-27; discussion 1429-40. PubMed ID: 8543957
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pulmonary manifestations of the eosinophilia-myalgia syndrome associated with tryptophan ingestion.
    Campagna AC; Blanc PD; Criswell LA; Clarke D; Sack KE; Gold WM; Golden JA
    Chest; 1992 May; 101(5):1274-81. PubMed ID: 1582284
    [TBL] [Abstract][Full Text] [Related]  

  • 28. L-tryptophan and the eosinophilia-myalgia syndrome.
    Drug Ther Bull; 1990 May; 28(10):37-8. PubMed ID: 2131206
    [No Abstract]   [Full Text] [Related]  

  • 29. 1,1'-Ethylidenebis[L-tryptophan], an impurity in L-tryptophan associated with eosinophilia-myalgia syndrome, stimulates type I collagen gene expression in human fibroblasts in vitro.
    Zangrilli JG; Mayeno AN; Vining V; Varga J
    Biochem Mol Biol Int; 1995 Nov; 37(5):925-33. PubMed ID: 8624499
    [TBL] [Abstract][Full Text] [Related]  

  • 30. L-tryptophan-related eosinophilia-myalgia syndrome possibly associated with a chronic B-lymphocytic leukemia.
    Böhme A; Wolter M; Hoelzer D
    Ann Hematol; 1998 Nov; 77(5):235-8. PubMed ID: 9858150
    [TBL] [Abstract][Full Text] [Related]  

  • 31. L-tryptophan and the eosinophilia-myalgia syndrome: current understanding of the etiology and pathogenesis.
    Varga J; Jimenez SA; Uitto J
    J Invest Dermatol; 1993 Jan; 100(1):97S-105S. PubMed ID: 8423409
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Scleroderma and environment. III. Eosinophilia-myalgia syndrome and L-tryptophan].
    Bournerias I; Castot A
    Ann Dermatol Venereol; 1991; 118(12):962-8. PubMed ID: 1799247
    [No Abstract]   [Full Text] [Related]  

  • 33. L-tryptophan and eosinophilia-myalgia syndrome.
    Mitchell N
    Med J Aust; 1993 Mar; 158(5):363-4. PubMed ID: 8329035
    [No Abstract]   [Full Text] [Related]  

  • 34. Presence of peak X and related compounds: the reported contaminant in case related 5-hydroxy-L-tryptophan associated with eosinophilia-myalgia syndrome.
    Johnson KL; Klarskov K; Benson LM; Williamson BL; Gleich GJ; Naylor S
    J Rheumatol; 1999 Dec; 26(12):2714-7. PubMed ID: 10606395
    [No Abstract]   [Full Text] [Related]  

  • 35. Eosinophilia-myalgia syndrome associated with ingestion of L-tryptophan.
    Keating JP; Wardill K; Viggiano J
    N Z Med J; 1992 Aug; 105(939):317. PubMed ID: 1386918
    [No Abstract]   [Full Text] [Related]  

  • 36. [Eosinophilic myalgia from L-tryptophan].
    Hardelin D; Saviuc P; Mallaret M; Brousse P; Danel V
    J Toxicol Clin Exp; 1990 Oct; 10(6):409-12. PubMed ID: 2130184
    [No Abstract]   [Full Text] [Related]  

  • 37. Pathogenesis of L-tryptophan eosinophilia myalgia syndrome.
    Sternberg EM
    Adv Exp Med Biol; 1996; 398():325-30. PubMed ID: 8906284
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Eosinophilic fasciitis associated with tryptophan ingestion. A manifestation of eosinophilia-myalgia syndrome.
    Gordon ML; Lebwohl MG; Phelps RG; Cohen SR; Fleischmajer R
    Arch Dermatol; 1991 Feb; 127(2):217-20. PubMed ID: 1990986
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Acute pleuropericarditis with eosinophilia after ingestion of tryptophan].
    Dell'Isola B; Rezgui N; Thiollieres JM; Labrousse J; Lissac J; Valcke JC
    Rev Med Interne; 1993 May; 14(5):353-4. PubMed ID: 8235154
    [No Abstract]   [Full Text] [Related]  

  • 40. Eosinophilia-myalgia syndrome in association with L-tryptophan ingestion.
    Gresh JP; Vasey FB; Espinoza LR; Adelman HM; Germain BF
    J Rheumatol; 1990 Nov; 17(11):1557-8. PubMed ID: 2273503
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.